Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
35.43
-0.34 (-0.95%)
Dec 20, 2024, 4:00 PM EST - Market closed
Supernus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 59.71 | 1.32 | 60.71 | 53.42 | 126.95 | 113.06 | Upgrade
|
| Depreciation & Amortization | 83.25 | 84.86 | 85.54 | 32.6 | 18.14 | 6.66 | Upgrade
|
| Other Amortization | - | 0.53 | 2.11 | 17.5 | 16.58 | 15.71 | Upgrade
|
| Asset Writedown & Restructuring Costs | 20.19 | 20.19 | - | 15 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.22 | -0.12 | 3.22 | 0.07 | -7.24 | -4.34 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | -12.89 | - | - | - | Upgrade
|
| Stock-Based Compensation | 26.57 | 26.76 | 17.57 | 17.91 | 16.56 | 14.85 | Upgrade
|
| Other Operating Activities | -25.48 | -13.31 | -15.2 | -12.94 | 3.92 | -3.61 | Upgrade
|
| Change in Accounts Receivable | -3.64 | 18.77 | -16.37 | 3.87 | -34.61 | 15.75 | Upgrade
|
| Change in Inventory | 17.65 | 6.11 | -17.86 | -14.58 | -10.12 | -0.97 | Upgrade
|
| Change in Accounts Payable | -14.87 | -36.29 | -19.16 | 18.18 | 8.27 | -11.68 | Upgrade
|
| Change in Other Net Operating Assets | 5.91 | 2.28 | 29.14 | -3.9 | -0.06 | -2.3 | Upgrade
|
| Operating Cash Flow | 172.5 | 111.09 | 116.83 | 127.13 | 138.4 | 143.13 | Upgrade
|
| Operating Cash Flow Growth | 84.12% | -4.91% | -8.10% | -8.14% | -3.30% | 10.96% | Upgrade
|
| Capital Expenditures | -0.48 | -0.55 | -0.41 | -2.05 | -3.69 | -1.39 | Upgrade
|
| Cash Acquisitions | - | - | - | -311.69 | -298.54 | - | Upgrade
|
| Investment in Securities | -242.73 | 269.28 | -216.25 | 231.82 | 267.53 | -156.54 | Upgrade
|
| Investing Cash Flow | -243.21 | 268.73 | -216.66 | -81.91 | -34.7 | -157.92 | Upgrade
|
| Short-Term Debt Issued | - | 93 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.8 | - | - | Upgrade
|
| Total Debt Issued | - | 93 | - | 0.8 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -93 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -402.5 | - | -138.32 | -0.8 | - | Upgrade
|
| Total Debt Repaid | - | -495.5 | - | -138.32 | -0.8 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -402.5 | - | -137.52 | -0.8 | - | Upgrade
|
| Issuance of Common Stock | 9.12 | 6.61 | 12.42 | 7.1 | 4.36 | 3.93 | Upgrade
|
| Repurchase of Common Stock | -1.73 | -1.99 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -22.9 | - | - | - | Upgrade
|
| Financing Cash Flow | 7.4 | -397.88 | -10.48 | -130.42 | 3.56 | 3.93 | Upgrade
|
| Net Cash Flow | -63.31 | -18.07 | -110.31 | -85.21 | 107.26 | -10.87 | Upgrade
|
| Free Cash Flow | 172.03 | 110.53 | 116.41 | 125.08 | 134.71 | 141.74 | Upgrade
|
| Free Cash Flow Growth | 84.75% | -5.05% | -6.93% | -7.15% | -4.96% | 10.61% | Upgrade
|
| Free Cash Flow Margin | 26.39% | 18.19% | 17.45% | 21.57% | 25.89% | 36.09% | Upgrade
|
| Free Cash Flow Per Share | 3.09 | 1.99 | 1.89 | 2.30 | 2.51 | 2.63 | Upgrade
|
| Cash Interest Paid | - | 1.95 | 2.52 | 2.52 | 2.52 | 2.52 | Upgrade
|
| Cash Income Tax Paid | 49.89 | 36.6 | 16.2 | 25.19 | 45.43 | 51.54 | Upgrade
|
| Levered Free Cash Flow | 162.93 | 161.71 | 89.54 | 116.37 | 137.93 | 121.74 | Upgrade
|
| Unlevered Free Cash Flow | 162.93 | 162.69 | 91.84 | 113.51 | 136.2 | 120.22 | Upgrade
|
| Change in Net Working Capital | -15.61 | -43.24 | 39.37 | -15.37 | 4.57 | -7.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.